Relfydess vs Botox: What’s the Difference and How Long Does It Last?

A new neuromodulator, Relfydess, has recently launched in New Zealand, adding another option to the growing range of anti-wrinkle treatments available to patients. Developed by Galderma, the product uses botulinum toxin type A to temporarily relax targeted facial muscles, helping to soften lines caused by repeated expression. 

Since the early 2000s, Botox has been the biggest buzzword in aesthetic medicine. What many people don’t realise is that Botox is just one brand of anti-wrinkle injections, medically known as neuromodulators. These treatments use purified botulinum toxin type A to temporarily block the nerve signals that trigger muscle contraction, helping smooth lines and wrinkles caused by facial movement. 

While the fundamentals of how anti-wrinkle injections work remain the same, innovation in neuromodulation continues to evolve. 

What is Relfydess? 

Relfydess is a ready to use botulinum toxin type A treatment indicated for moderate to severe frown lines and crow’s feet in adults. 

Key features 

• High purity formulation (PEARL™ technology): Designed to include only the active neurotoxin molecule and exclude complexing proteins and certain additives. 
• Ready to use liquid: Supplied preprepared, which may support dosing consistency in clinical settings. 
• Onset and duration: Clinical studies reported some patients noticing effects within a few days, with results lasting around six months for many individuals. 

What this means for you 

For people considering anti-wrinkle injections, Relfydess represents an additional option rather than a replacement for existing neuromodulators. Some patients may value the potential for earlier visible results or longer duration, while others may see similar outcomes to established treatments. 

As with all neuromodulators, results vary depending on the individual, treatment area, and injector technique. A consultation with a qualified medical professional is important to determine suitability and expected outcomes. 

The bigger picture 

New Zealand’s aesthetics market continues to expand as more clients seek minimally invasive options with little downtime, and the introduction of new products like Relfydess reflects ongoing development within the neuromodulator category. Neuromodulator treatments remain among the most requested procedures globally due to their strong safety profile and predictable outcomes. 

Next time you’re in clinic, be sure to ask us if Relfydess could by right for you.